Recall StatusOpen, Classified
Date Initiated2022-03-25
Product Quantity2502 total: 2154 US; 348 OUS
Reason for Recall
Falsely high or delayed patient and QC results may occur due to low end imprecision. VITROS Immunodiagnostic Products FSH, LH and Prol Reagents Low End Imprecision. Low-level quality control (QC) and patient samples at the low end of the Measuring (Reportable) Range when using VITROS FSH, LH and Prol Reagent. Calibration failures, driven by imprecision observed with Calibrator Level 1.
Firm Action
Ortho CLinical Diagnostics issued "URGENT PRODUCT CORRECTION NOTIFICATION" dated 3/25/22 to consignees who had been shipped VITROS FSH, LH or Prol in the previous 18 months were notified (CL2022-069) of the issue and instructed as follows:
-Run daily low-level QC in duplicate to confirm acceptable performance.
-If their laboratory is experiencing low end imprecision with VITROS FSH, LH or Prol Reagent, follow one of the suggested testing algorithms as described in the enclosure.
o Note: If their laboratory is not experiencing low end imprecision, continue testing patient samples as usual (single replicate).
-Until further notice, all future lots of the products will also be affected.
-On the enclosed Credit Form, track the additional quantities of VITROS FSH, LH and/or Prol tests used due to the testing protocol. Periodically submit the form to Ortho. Ortho will credit their account.
If you have further questions, please contact Ortho Care Technical Solutions Center at 1-800-421-3311.
Distribution Pattern
Worldwide Distribution:
US (Nationwide)
OUS (Foreign):
Australia
Bermuda
Brazil
Canada L3R 4G5
Chile
China
Colombia
Denmark
France
Germany
India
Italy
Japan
Mexico
Netherlands
Norway
Portugal
Russia
Singapore
Spain
Sweden
United Kingdom
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.